EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2004. Start Trial.
Date Value
December 31, 2015 -1.600
September 30, 2015 -1.950
June 30, 2015 -1.401
March 31, 2015 -0.9859
December 31, 2014 -0.6086
September 30, 2014 -0.6455
June 30, 2014 -0.5345
March 31, 2014 -0.9594
December 31, 2013 0.5957
September 30, 2013 -0.5632
June 30, 2013 -0.6664
March 31, 2013 -0.3369
December 31, 2012 0.1103
September 30, 2012 -0.0001
June 30, 2012 -0.7633
March 31, 2012 7.805
December 31, 2011 -3.896
September 30, 2011 -1.080
June 30, 2011 -0.1224
March 31, 2011 -1.164
December 31, 2010 -0.9232
September 30, 2010 -1.319
June 30, 2010 -0.6479
March 31, 2010 -1.411
Date Value
December 31, 2009 -1.508
September 30, 2009 -1.581
June 30, 2009 -1.622
March 31, 2009 -1.551
December 31, 2008 -1.751
September 30, 2008 -0.8939
June 30, 2008 -4.651
March 31, 2008 -0.8916
December 31, 2007 -2.832
September 30, 2007 2.922
June 30, 2007 -4.589
March 31, 2007 -2.786
December 31, 2006 -3.070
September 30, 2006 -1.192
June 30, 2006 -3.638
March 31, 2006 -3.376
December 31, 2005 -3.740
September 30, 2005 6.224
June 30, 2005 -2.675
March 31, 2005 -3.234
December 31, 2004 -6.063
September 30, 2004 -4.470
June 30, 2004 12.40
March 31, 2004 -2.232

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
CureVac NV 1.414
Anbio Biotechnology --
Epigenomics AG --
ACADIA Pharmaceuticals, Inc. 0.1822
Alkermes Plc 0.0029